AR051051A1 - Antibioticos de piperidina - Google Patents

Antibioticos de piperidina

Info

Publication number
AR051051A1
AR051051A1 ARP050104194A ARP050104194A AR051051A1 AR 051051 A1 AR051051 A1 AR 051051A1 AR P050104194 A ARP050104194 A AR P050104194A AR P050104194 A ARP050104194 A AR P050104194A AR 051051 A1 AR051051 A1 AR 051051A1
Authority
AR
Argentina
Prior art keywords
alkyl
haloalkyl
alkoxy
aryl
halogen
Prior art date
Application number
ARP050104194A
Other languages
English (en)
Original Assignee
Actelion Percurex Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35453391&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR051051(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Actelion Percurex Ag filed Critical Actelion Percurex Ag
Publication of AR051051A1 publication Critical patent/AR051051A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Reivindicación 1: Un compuesto seleccionado desde el grupo consistente de un compuesto de la fórmula (1) donde uno de U y V representa N, el oro representa N o CH; M representa CH₂CH₂, CH=CH, CH(OH)CH(OH), CH(OH)CH₂, CH(NH₂)CH₂, COCH₂ o OCH₂; R¹ representa alquil, haloalquil, alcoxi, haloalcoxi, halógeno o ciano; R² representa H o halógeno; R³ representa carboxi, carboxamido, alquilaminocarbonil, hidroxi, aminocarboniloxi, 2-tetrazolil o 3-metil-1,2,4-oxadiazol-5-il; R⁴ representa alquil, alcoxi C₁₋₄-alquil C₁₋₄, haloalquil, alquenil, arilalquil, aril-S(O)ₘ-alquil, heteroarilalquil, heteroarilaminocarbonilalquil, heteroaril-S(O)ₘ-alquil, CH₂-CH=CH-aril o cicloalquil-S(O)ₘ-alquil; n es un entero desde 0 a 3; y m es 0 ó 2; y una prodroga, un tautómero, un enantiómero ópticamente puro, mezclas de enantiómeros, un racemato, un distereoisómero ópticamente puro, mezclas de diatereoisómeros, un racemato diastereoisomérico, mezcla de racematos diatereoisoméricos, una forma meso, una forma morfológica, una sal o un complejo solvente de tales compuestos.
ARP050104194A 2004-10-05 2005-10-04 Antibioticos de piperidina AR051051A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP2004011087 2004-10-05

Publications (1)

Publication Number Publication Date
AR051051A1 true AR051051A1 (es) 2006-12-13

Family

ID=35453391

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050104194A AR051051A1 (es) 2004-10-05 2005-10-04 Antibioticos de piperidina

Country Status (10)

Country Link
US (1) US20070173532A1 (es)
JP (1) JP2008515796A (es)
CN (1) CN101039935B (es)
AR (1) AR051051A1 (es)
AT (1) ATE466857T1 (es)
CA (1) CA2581057A1 (es)
DE (1) DE602005021133D1 (es)
ES (1) ES2343127T3 (es)
TW (1) TW200616959A (es)
WO (1) WO2006038172A1 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2330670T3 (es) * 2005-05-25 2009-12-14 Actelion Pharmaceuticals Ltd. Nuevos derivados antibioticos.
MY150958A (en) 2005-06-16 2014-03-31 Astrazeneca Ab Compounds for the treatment of multi-drug resistant bacterial infections
BRPI0617376A2 (pt) * 2005-10-13 2011-07-26 Morphochem Ag derivados de 5-quinolina tendo uma atividade antibacteriana
DE602007009205D1 (de) 2006-04-06 2010-10-28 Glaxo Group Ltd Pyrrolochinoxalinonderivate als antibakterielle mittel
GB0613208D0 (en) 2006-07-03 2006-08-09 Glaxo Group Ltd Compounds
EP1992628A1 (en) 2007-05-18 2008-11-19 Glaxo Group Limited Derivatives and analogs of N-ethylquinolones and N-ethylazaquinolones
TW200819457A (en) * 2006-08-30 2008-05-01 Actelion Pharmaceuticals Ltd Spiro antibiotic derivatives
MY149347A (en) * 2007-04-20 2013-08-30 Glaxo Group Ltd Tricyclic nitrogen containing compounds as antibacterial agents
EP2080761A1 (en) 2008-01-18 2009-07-22 Glaxo Group Limited Compounds
JP2012505866A (ja) 2008-10-17 2012-03-08 グラクソ グループ リミテッド 抗菌剤として使用される三環式窒素化合物
WO2010081874A1 (en) 2009-01-15 2010-07-22 Glaxo Group Limited Naphthyridin-2 (1 h)-one compounds useful as antibacterials
US9085557B2 (en) 2010-05-06 2015-07-21 Council Of Scientific And Industrial Research Quinolylpiperazino substituted thiolactone compounds and process for the preparation thereof
BR112017003705B1 (pt) 2014-08-22 2022-07-12 Glaxosmithkline Intellectual Property Development Limited Compostos contendo nitrogênio tricíclicos para o tratamento de infecção por neisseria gonorrhoea
TW201722965A (zh) 2015-08-16 2017-07-01 葛蘭素史密斯克藍智慧財產發展有限公司 用於抗菌應用之化合物
NZ763766A (en) 2017-03-20 2023-07-28 Novo Nordisk Healthcare Ag Pyrrolopyrrole compositions as pyruvate kinase (pkr) activators
BR112021005188A2 (pt) 2018-09-19 2021-06-08 Forma Therapeutics, Inc. tratamento de anemia falciforme com um composto de ativação de piruvato cinase r
EP3852791B1 (en) 2018-09-19 2024-07-03 Novo Nordisk Health Care AG Activating pyruvate kinase r

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9822450D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
WO2000043383A1 (en) * 1999-01-20 2000-07-27 Smithkline Beecham P.L.C. Piperidinylquinolines as protein tyrosine kinase inhibitors
FR2798656B1 (fr) * 1999-09-17 2004-12-17 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leur preparation et les compositions qui les contiennent
GB0112836D0 (en) * 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
AR040336A1 (es) * 2002-06-26 2005-03-30 Glaxo Group Ltd Compuesto de piperidina, uso del mismo para la fabricacion de un medicamento, composicion farmaceutica que lo comprende y procedimiento para preparar dicho compuesto
TW200406413A (en) * 2002-06-26 2004-05-01 Glaxo Group Ltd Compounds
FR2844268B1 (fr) * 2002-09-11 2004-10-22 Aventis Pharma Sa Derives de la quinolyl propyl piperidine, leurs procedes et intermediaires de preparation et les compositions qui les contiennent
WO2004035569A2 (de) * 2002-10-10 2004-04-29 Morphochem Aktiengesellschaft für kombinatorische Chemie Neue verbindungen mit antibakterieller aktivität
DE10247233A1 (de) * 2002-10-10 2004-06-17 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen, die Topoisomerase IV inhibieren
US6982334B2 (en) * 2002-12-20 2006-01-03 Aventis Pharma S.A. Crystalline form of (3R,4R)-4-[3-(S)-hydroxy-3-(6-methoxyquinolin-4-yl)propyl]-1-[2-(2-thienylthio)ethyl]piperindine-3-carboxylic acid
DE10316081A1 (de) * 2003-04-08 2004-10-21 Morphochem AG Aktiengesellschaft für kombinatorische Chemie Neue Verbindungen mit antibakterieller Aktivität

Also Published As

Publication number Publication date
CN101039935A (zh) 2007-09-19
WO2006038172A1 (en) 2006-04-13
TW200616959A (en) 2006-06-01
US20070173532A1 (en) 2007-07-26
ATE466857T1 (de) 2010-05-15
CA2581057A1 (en) 2006-04-13
CN101039935B (zh) 2011-04-20
DE602005021133D1 (de) 2010-06-17
JP2008515796A (ja) 2008-05-15
ES2343127T3 (es) 2010-07-23

Similar Documents

Publication Publication Date Title
AR051051A1 (es) Antibioticos de piperidina
CO6160231A2 (es) Compuestos de isoindolina 5-substituidos
RS54786B1 (sr) Nova jedinjenja koja moduliraju fxr (nr1h4)
PE20141075A1 (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas que contienen un grupo sulfoximina
EA200802389A1 (ru) Азиридинилэпотилоновые соединения
AR085615A1 (es) Derivados de fluoropiridinona utiles como agentes antibacterianos y composiciones farmaceuticas que los contienen
AR082696A1 (es) Derivados heterociclicos nitrogenados de 1,2,4-oxadiazol, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de enfermedades cardiovasculares e inflamatorias, entre otras
RS53812B1 (en) NEW UNITS THAT CONNECT TO FXR (NR1H4) AND MODULATE ITS ACTIVITY
EA200700758A1 (ru) Новые производные бис-азаиндолов, их получение и фармацевтическое применение в качестве ингибиторов киназ
CO6160291A2 (es) Compuestos que modulan al receptor cb2
PE20140609A1 (es) Diazacarbazoles y metodos de uso
AR084913A1 (es) Derivados de aril-benzocicloalquil-amida
AR062797A1 (es) Derivados de piperidina como inhibidores de renina, composiciones farmaceuticas.
AR073136A1 (es) Compuestos de pirrol
AR052866A1 (es) Fenil-metanonas monociclicas sustituidas
AR050266A1 (es) Derivados de bencil-triazolona como inhibidores no nucleosidos de transcriptasa inversa
EA200800372A1 (ru) Соединения и их соли, специфичные к ppar рецепторам и egf рецепторам, и их применение в области медицины
AR053774A1 (es) Derivados de sulfonilbencimidazol. composiciones farmaceuticas.
AR057980A1 (es) Derivados de la 1- amino-ftalazina sustituida, su preparacion y composicion farmaceutica
CO5700747A2 (es) Piperidinas novedosas como moduladores de quimoquina (ccr)
RS52900B (en) Benzoylpyrazole Compound, Process for Production and Production of Herbicides Containing Them
RS53909B1 (en) 5- (Phenyl / pyridinyl-ethynyl) -2-pyridine / 2-pyrimidine carboxamides as modulators of MGLUR5
TW200637816A (en) Substituted indole compound
AR060379A1 (es) Compuesto y composicion herbicida
AR083861A1 (es) OXAZOLIDINONAS COMO MODULADORES DE mGluR5 Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN

Legal Events

Date Code Title Description
FB Suspension of granting procedure